BlackRock Health Sciences Trust II (BMEZ)
14.46
-0.23
(-1.57%)
USD |
NYSE |
Apr 25, 12:44
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 1.32% | -15.91% | 1.861B | 258952.9 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0% | 63.00% | -- | Upgrade |
Basic Info
| Investment Strategy | |
| To provide total return and income through a combination of current income, current gains and long-term capital appreciation. Under normal market conditions, the Trust will invest at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. |
| General | |
| Security Type | Closed-End Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Income |
| Fund Owner Firm Name | BlackRock |
| Prospectus Benchmark Index | |
| MSCI ACWI SMID Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Christopher Accettella | 4.18 yrs |
| Erin Xie | 4.18 yrs |
| Kyle McClements | 4.18 yrs |
| Xiang Liu | 4.18 yrs |
Performance Versus Category
As of April 24, 2024. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of April 24, 2024.
Basic Info
| Investment Strategy | |
| To provide total return and income through a combination of current income, current gains and long-term capital appreciation. Under normal market conditions, the Trust will invest at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. |
| General | |
| Security Type | Closed-End Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Income |
| Fund Owner Firm Name | BlackRock |
| Prospectus Benchmark Index | |
| MSCI ACWI SMID Growth TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Christopher Accettella | 4.18 yrs |
| Erin Xie | 4.18 yrs |
| Kyle McClements | 4.18 yrs |
| Xiang Liu | 4.18 yrs |